rs4147358

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_005902.4(SMAD3):​c.207-29219C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.309 in 151,928 control chromosomes in the GnomAD database, including 8,109 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.31 ( 8109 hom., cov: 31)

Consequence

SMAD3
NM_005902.4 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.00500

Publications

17 publications found
Variant links:
Genes affected
SMAD3 (HGNC:6769): (SMAD family member 3) The SMAD family of proteins are a group of intracellular signal transducer proteins similar to the gene products of the Drosophila gene 'mothers against decapentaplegic' (Mad) and the C. elegans gene Sma. The SMAD3 protein functions in the transforming growth factor-beta signaling pathway, and transmits signals from the cell surface to the nucleus, regulating gene activity and cell proliferation. This protein forms a complex with other SMAD proteins and binds DNA, functioning both as a transcription factor and tumor suppressor. Mutations in this gene are associated with aneurysms-osteoarthritis syndrome and Loeys-Dietz Syndrome 3. [provided by RefSeq, May 2022]
SMAD3 Gene-Disease associations (from GenCC):
  • aneurysm-osteoarthritis syndrome
    Inheritance: AD, Unknown Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, ClinGen, Labcorp Genetics (formerly Invitae), G2P
  • familial thoracic aortic aneurysm and aortic dissection
    Inheritance: AD, Unknown Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_005902.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.584 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_005902.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SMAD3
NM_005902.4
MANE Select
c.207-29219C>A
intron
N/ANP_005893.1P84022-1
SMAD3
NM_001407011.1
c.207-29219C>A
intron
N/ANP_001393940.1H3BQ00
SMAD3
NM_001407012.1
c.207-29219C>A
intron
N/ANP_001393941.1A0AAQ5BHI7

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SMAD3
ENST00000327367.9
TSL:1 MANE Select
c.207-29219C>A
intron
N/AENSP00000332973.4P84022-1
SMAD3
ENST00000540846.6
TSL:1
c.-110+9692C>A
intron
N/AENSP00000437757.2P84022-3
SMAD3
ENST00000560424.2
TSL:3
c.207-29219C>A
intron
N/AENSP00000455540.2H3BQ00

Frequencies

GnomAD3 genomes
AF:
0.309
AC:
46917
AN:
151810
Hom.:
8095
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.413
Gnomad AMI
AF:
0.208
Gnomad AMR
AF:
0.358
Gnomad ASJ
AF:
0.335
Gnomad EAS
AF:
0.602
Gnomad SAS
AF:
0.434
Gnomad FIN
AF:
0.172
Gnomad MID
AF:
0.313
Gnomad NFE
AF:
0.224
Gnomad OTH
AF:
0.329
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.309
AC:
46973
AN:
151928
Hom.:
8109
Cov.:
31
AF XY:
0.312
AC XY:
23142
AN XY:
74234
show subpopulations
African (AFR)
AF:
0.413
AC:
17100
AN:
41394
American (AMR)
AF:
0.359
AC:
5480
AN:
15264
Ashkenazi Jewish (ASJ)
AF:
0.335
AC:
1162
AN:
3464
East Asian (EAS)
AF:
0.602
AC:
3113
AN:
5174
South Asian (SAS)
AF:
0.434
AC:
2091
AN:
4822
European-Finnish (FIN)
AF:
0.172
AC:
1810
AN:
10520
Middle Eastern (MID)
AF:
0.316
AC:
93
AN:
294
European-Non Finnish (NFE)
AF:
0.224
AC:
15245
AN:
67978
Other (OTH)
AF:
0.327
AC:
690
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1559
3118
4676
6235
7794
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
472
944
1416
1888
2360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.261
Hom.:
19602
Bravo
AF:
0.328
Asia WGS
AF:
0.489
AC:
1698
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.78
CADD
Benign
8.3
DANN
Benign
0.57
PhyloP100
0.0050
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs4147358;
hg19: chr15-67428014;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.